Uterus myoma. Leiomyoma of uterus, unspecified
Conditions
Interventions
Intervention 1: Intervention group: as soon as the hysteroscope enters the uterus, an ampoule of tranexamic acid from Iran Daru 10 mg/kg will be injected into the uterus.p:. Intervention 2: Control gr
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Have a single myoma Grade 0, 1, and 2 myomas Myomas smaller than 4 cm
Exclusion criteria
Exclusion criteria: Have intracranial bleeding Have any sensitivity to the drug tranexamic acid Have thromboembolic and ischemic heart diseases There are uterine abnormalities Have an active pelvic infection Have a history of hemorrhagic disease Pregnancy Previous hystreroscopy surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Better vision during surgery. Timepoint: During surgery. Method of measurement: Surgeon rating.;Bleeding during surgery. Timepoint: During surgery. Method of measurement: Surgeon rating.;Duration of operation. Timepoint: From the beginning of surgery to the end of surgery. Method of measurement: Minutes.;Hemoglobin reduction rate. Timepoint: Before the operation and 24 hours after the operation. Method of measurement: Milligram on deciliter.;Complications of the operation. Timepoint: During or after surgery. Method of measurement: Patient symptoms.;The completeness of the operation in one step. Timepoint: One month after surgery. Method of measurement: Sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNadia Arabpour amroudi
Kerman University of Medical Sciences
Outcome results
None listed